Skip to main content
SupplementScience

Benefits of Probiotics (Lactobacillus)

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Antibiotic-associated diarrhea prevention — a Cochrane review (Goldenberg et al., 2017, 31 RCTs, n=8,672) found L. rhamnosus GG significantly reduces AAD risk with NNT of 7
  • IBS symptom relief — Ducrotté et al. (2012, n=214) demonstrated L. plantarum 299v significantly reduced abdominal pain and bloating scores vs placebo in IBS patients
  • Infantile colic — Savino et al. (2010, n=50) showed L. reuteri DSM 17938 reduced daily crying time by 74% vs placebo at 21 days
  • Immune modulation — L. rhamnosus GG upregulates secretory IgA production in the gut mucosa, enhancing mucosal immune defense (Kaila et al., 1992)

What the Research Says

Lactobacillus is the most extensively studied probiotic genus with thousands of clinical trials. The evidence base is strongest for L. rhamnosus GG (AAD prevention, pediatric diarrhea), L. plantarum 299v (IBS), L. reuteri DSM 17938 (infantile colic), and L. acidophilus (lactose digestion). A critical principle is strain specificity — clinical benefits are tied to specific strains, not the genus as a whole. The AGA conditionally recommends L. rhamnosus GG for AAD prevention and L. reuteri for infantile colic based on moderate-quality evidence.

Related Conditions

Gut HealthIbsImmune Support
Full Probiotics (Lactobacillus) Guide

References

  1. (). Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews. DOI
  2. (). Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World Journal of Gastroenterology. DOI